Hence, several studies have investigated PDE5 inhibitors as treatment options for BPH in men with and without erectile dysfunction (ED) who suffer from LUTS such as urinary frequency, urinary urgency, incomplete emptying, weak urinary stream, straining, or intermittence [12]. The gene discussed is PDE5A; the disease is benign prostatic hyperplasia.